Error: Could not add to watchlist. X
+ Watchlist

Adamis Pharmaceuticals Corp

CY3A:GR
Ticker Delisted
4.24
EUR
As of 11:40 AM EDT 6/28/2017
Open
4.23
Day Range
4.23 - 4.33
Volume
175
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
4.23
Day Range
4.23 - 4.33
Volume
175
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.49%
% Price Change
+0.52%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Adamis Pharmaceuticals Corporation is a bio-pharmaceuticals company. The Company develops and distributes specialty pharmaceutical products in the therapeutic areas of oncology, immunology, infectious diseases, allergy and respiratory. Adamis Pharmaceuticals offers its products to the healthcare industry.
Address
11682 El Camino Real
Suite 300
San Diego, CA 92130
United States
Phone
1-858-997-2400
  • Dennis J Carlo
    President/CEO/Co-Founder
  • Eddie W Glover
    CEO:US Compounding
  • David J Marguglio
    Senior VP:Corporate Dev/Chief Bus Ofcr
  • Robert O Hopkins
    VP:Finance/CFO
  • Karen K Daniels
    VP:Operations
Show More